Singapore, Sept. 2 -- Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), bringing together the laboratory, biotechnology, chemicals and lif... Read More
Singapore, Sept. 2 -- "Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens earlier in the process than founders imagine, and for rea... Read More
Singapore, Sept. 2 -- Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a structure with one engineered end and one improvised end, and S... Read More
Singapore, Sept. 2 -- Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investigational once-daily oral small molecule GLP-1 receptor agon... Read More
Singapore, Sept. 2 -- Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran for transthyretin amyloidosis. From 1 September 2026, vut... Read More
Singapore, Sept. 2 -- Singapore is expanding subsidised access to Roche's Columvi, or glofitamab, for eligible patients with relapsed or refractory diffuse large B-cell lymphoma. From 1 September 202... Read More
Singapore, Sept. 1 -- The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on stage. The fourth edition of the Asia Bio Partnering For... Read More
Singapore, Sept. 1 -- A session billed as a conversation about partnering was, on closer inspection, something rather more useful: a pricing signal, delivered by the only people in the room who set pr... Read More
Singapore, Sept. 1 -- Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to generate broad-spectrum immune responses, and GC Biopharm... Read More
Singapore, Aug. 31 -- Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasing contributions from innovative drugs, pipeline progress ... Read More